Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy
Gowoon Yang(Yonsei University), Kyung Hwan Kim(Yonsei University), Joongyo Lee(Yonsei University), Jihun Kim(Chungbuk National University), Jee Suk Chang(Yonsei University), Hong In Yoon(Yonsei University), Yeona Cho(Gangnam Severance Hospital), Chang Geol Lee(Yonsei University), Jaeho Cho(Yonsei University), Jin Sung Kim(Yonsei University), Hojin Kim(Yonsei University)
Cited by 18
Related Papers
Emission color variation of M2SiO4:Eu2+ (M=Ba, Sr, Ca) phosphors for light-emitting diode
|Solid State Communications|2004|224
Bojungikki-Tang for Cancer-Related Fatigue: A Pilot Randomized Clinical Trial
|Integrative Cancer Therapies|2010|161